Navigation Links
£20 million to fight virtual crime and treat our aging population
Date:11/20/2008

Fighting virtual crime, treating an ageing population, and turning research into commercial enterprises, will be the focus of a 20 million ($30.4 million) investment announced today by the Engineering and Physical Sciences Research Council (EPSRC), Technology Strategy Board (TSB) and the Biotechnology and Biological Sciences Research Council (BBSRC).

This new investment will create two new centres in areas where world-class scientific breakthroughs have already been achieved. These 'Innovation and Knowledge Centres' (IKCs) will mix business knowledge with the most up-to-date research to harness the full potential of emerging technologies ensuring the UK is first to develop this cutting-edge research.

The two new centres will be based at Queen's University Belfast and the University of Leeds. Belfast's new centre will work to secure our information architecture, and safeguard the trustworthiness of information stored electronically, including countering malicious 'cyber-attack'. The University of Leeds Centre will work on regenerative techniques and technologies to treat the common ailments of an ageing population.

EPSRC's Chief Executive, Professor David Delpy, said "Taking exciting research from the university laboratory to the commercial sector through close collaboration with user stakeholders is vital to ensuring the UK's economy continues to be innovative and globally competitive.

EPSRC is strongly committed to supporting universities in commercialising their outstanding research and I applaud the innovative approach taken by the successful applicants, and all competing universities."

Minister of State for Science and Innovation, Lord Drayson, said "More public money than ever before is being spent on world leading research into the strategic challenges facing the UK such as the world's ageing population and security.

He continued: "The investment in these two new Innovation and Knowledge Centres will foster an en
'/>"/>

Contact: Lawrie Jones
lawrie.jones@epsrc.ac.uk
44-01-793-444-404
Engineering and Physical Sciences Research Council
Source:Eurekalert

1

GOOD

Page: 1 2 3

Related biology news :

1. £20 million to fight virtual crime and treat our ageing population
2. Musculoskeletal center wins $2.2 million for drug safety
3. Deep heat solution to 500-million year mystery
4. L-1 Identity Solutions Selected by the State of New York as the Winning Bidder to Provide Enrollment Services for a Contract Estimated at Up to $250 Million
5. Eastman Dental Center awarded $1.6 million to find ways to prevent cavities
6. SAIC Awarded $37 Million Contract to Support U.S. Army Program Executive Office - Enterprise Information Systems
7. New $11 million center to speed production of new compounds for drug discovery
8. Missouri Botanical Garden mounts milestone 6 millionth herbarium specimen
9. FSU researchers discovery leads to $1.5 million grant, potential new treatment of liver fibrosis
10. L-1 Identity Solutions Awarded New Massachusetts RMV Drivers License Contract Valued at an Estimated $32 Million
11. L-1 Identity Solutions Receives $5.9 Million Drivers License Contract Expansion from the State of Mississippi

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...5, 2009 Soil is the linchpin of the environment, ... Despite that, many students see soil as "just dir... science educators are challenged with the task of...tical importance of soil in the environment. , ...science teachers at University of Nebraska-Lincoln...
(Date:11/24/2009)...itute (LRI) today named 12 new grant recipients fo...ze innovative work across a broad spectrum of lupu..., novelty, and potential to drive scientific disco...mplex disease of systemic lupus. , The 2009 gran...s across the nation and include interdisciplinary ...
(Date:11/24/2009)...an College of Medical Toxicology (ACMT) have signe...f the Journal of Medical Toxicology (JMT), the o...10. It was previously published by the University...al Toxicology , an international, peer-reviewed jo...ractice of medical toxicology. The quarterly jour...
Breaking Biology News(10 mins):It's not just dirt! 2Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3Springer and the American College of Medical Toxicology to work together 2Give Shoes the 26apos 3B1 2 3 Test 26apos 3B During Back To School Shopping 54914 1Give Shoes the 26apos 3B1 2 3 Test 26apos 3B During Back To School Shopping 54914 2Give Shoes the 26apos 3B1 2 3 Test 26apos 3B During Back To School Shopping 54914 3LSUHSC research discovers new targets for treatment of invasive breast cancer 54910 1LSUHSC research discovers new targets for treatment of invasive breast cancer 54910 2Life Expectancy in U S Hits a New High 54906 1Life Expectancy in U S Hits a New High 54906 2Life Expectancy in U S Hits a New High 54906 3
...ying for more food at supper. Sadly, Margie Fische... at her family,s dinner table for years. Her daugh...PKU), a genetic disease that means her body can,t ... PKU is described by scientists as an autosomal re... deficiency in an enzyme called phenylalanine hydr...
...ain causes it to become asymmetrical, according to... Asymmetry in the brain is thought to be important...perate more efficiently. , Left-right asymmetry i...st evident at the time of early brain development....echanisms that bring it about. Now, in a study fun...
...through in treating premature babies at risk of de...Dr Maria Makrides from the Women,s and Children,s ... from the University of Adelaide has demonstrated ...-term infants via their mother,s breast milk or in... The findings were published today in the Journal...
Other Biology News:New drug holds out promise of normal diet for sufferers of devastating PKU genetic disease 2New drug holds out promise of normal diet for sufferers of devastating PKU genetic disease 3Game of two halves leads to brain asymmetry 2World breakthrough in treating premature babies 2
(Date:11/24/2009)...IK, Iceland, November 24 ...nced the approval of all of its,"first day" motion... Delaware,(the "Bankruptcy Court"). deCODE last we...pter 11 of the United States Bankruptcy Code with ... by the Bankruptcy Court allow the company to cont...
(Date:11/24/2009)...24 /PRNewswire-Asia/ -- Shanghai Biolaxy announced...(SFDA) has approved the,investigational new drug a...lin), an innovative insulin formulation to treat d...ate its first phase I clinical study. , D... glucose and poor,metabolism. The complications of...
(Date:11/24/2009)...ndpoint has been met for patients with advanced-st...EBEC CITY, Nov. 24 /PRNewswire-FirstCall/ - AEtern...ompany"), a global biopharmaceutical company focus...ced positive efficacy data from a Phase 2 study wi...108 (formerly AN-152), in patients with advanced o...
(Date:11/24/2009)...2009 Arena Pharmaceutica...he company is scheduled to present at the Piper Ja...er 1, 2009 at 11:30 a.m. Eastern Time (8:30 a.m. P...ork City. Jack Lief, Arena,s President and Chief E...iew of the company, including its clinical develop...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Biolaxy Secures IND Approval for Oral Insulin 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 3
...,ICAD), an industry-leading provider of Computer-A...tion of cancer, today announced that John,DeLucia ...ssurance and,Regulatory Affairs, reporting to iCAD...ore than 25 years of medical device, in-vitro diag... key management position. Mr.,DeLucia has signific...
...Inc. (OTC Bulletin Board: AVGO), a late stage biot...stem therapeutics for neurodegenerative,diseases, ... Administration,(FDA) and will proceed with a Phas...the treatment of Huntington,s disease, pending fin...., A double-blind, placebo-controlled Phase III c...
...dcast you,will learn about how plant biotechnology...ate stress., Climatic conditions such as heat or ...arvest turns out well or badly. Because whenever t...themselves in a stressful,situation, literally. On...farmer,s work goes far beyond the mere production ...
Other Biology Technology:iCAD Appoints John DeLucia as Vice President of Quality Assurance and Regulatory Affairs 2iCAD Appoints John DeLucia as Vice President of Quality Assurance and Regulatory Affairs 3Avicena's HD-02 to Proceed to NIH Sponsored Phase III Huntington's Disease Trial 2Avicena's HD-02 to Proceed to NIH Sponsored Phase III Huntington's Disease Trial 3Avicena's HD-02 to Proceed to NIH Sponsored Phase III Huntington's Disease Trial 4BASF Podcast - Better Harvest in Spite of Climate Stress 2BASF Podcast - Better Harvest in Spite of Climate Stress 3
Goat Anti-T7 tag Polyclonal Antibody, Agarose Conjugated from GeneTex
Goat Anti-T7 Polyclonal Antibody, Agarose Conjugated from GeneTex
Rabbit Anti-Olfactory Receptor LS189744 Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-C/EBPdelta Polyclonal Antibody, Unconjugated from Cell Signaling Technology
Biology Products: